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Background
Bronchial asthma is traditionally viewed as an eosinophilic
airway inflammatory disorder with the involvement of Th2
cytokines. In refractory asthma, where chronic inflamma-
tion and airway remodeling are key pathological features,
it is suggested that the dysregulation of the Th1/Th2 cyto-
kines production modifies airway inflammation and airway
hyperrespnsiveness (AHR).
Interleukin (IL)-18, a pleiotropic proinflammatory cyto-
kine, contributes to the pathophysiology of asthma by
modulating airway inflammation. Aim of this study was
to investigate IL-18 levels in refractory asthma and its
relation to eosinophilic airway inflammation and airway
remodelling.
Method
IL-18 levels were measured in sputum supernatants
obtained from patients with mild asthma (21 smokers
and 24 non smokers), and patients with refractory
asthma (n=18). Eosinophilic airway inflammation was
assessed by measuring ECP, eosinophil counts in spu-
tum and AHR to methacholine. Airway remodelling was
assessed by measuring IL-13, VEGF and transforming
growth factor (TGF)-b1 in induced sputum.
Results
Patients with refractory asthma had significantly lower
IL-18 levels in sputum compared to smoking and non
smoking asthmatics (p<0.001). IL-18 levels were corre-
lated to the macrophages percentage (r=0.635, p=0.026)
and inversely correlated to neutrophils percentage in
sputum (r=-0.715, p=0.009). Furthermore, IL-18 levels
in sputum correlated to FEV1 (% pred) (r=0.760,
p=0.004), to FVC (% pred) (r=0.620, p=0.032), and to
PD20Mch (r=0.733, p=0.007). No correlations were
found between IL-18, ECP, TGF-1, VEGF levels, and
eosinophil counts in the sputum of refractory asthma.
Conclusion
These findings suggest that in refractory asthma IL-18 is
possibly involved in chronic airway inflammation and
airway remodelling through an eosinophil independent
pathway. The decreased levels of IL-18 in refractory
asthma might be the result of impaired inflammasome
activation in this asthma phenotype, justifying the sus-
ceptibility of these patients for infectious exacerbations.
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